Table 3. Activity of salvage chemotherapy.

Variable	All evaluable patients (n=31) (%)	Platinum-based chemotherapy (n=21) (%)	Single-agent chemotherapy (n=10) (%)
Response			0
CR	1 (3.2)	1 (4.8)	4 (40.0)
PR	12 (38.7)	8 (38.1)	2 (20.0)
SD	4 (12.9)	2 (9.5)	4 (40.0)
PD	14 (45.2)	10 (47.6)
Objective response
No. of patients	13 (41.9)	9 (42.9)	4 (40.0)
95% CI	25.6–60.3	25.5–67.0	8.9–71.9
Disease control
No. of patients	17 (54.8)	11 (52.4)	6 (60.0)

CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease; CI, confidence interval.